首页> 外文会议>International AIDS Conference >Antibodies Response Against V3 Loops Synthetic Peptides in Cuban B Subtype Patients
【24h】

Antibodies Response Against V3 Loops Synthetic Peptides in Cuban B Subtype Patients

机译:抗体对古巴B亚型患者的v3回复v3循环合成肽

获取原文

摘要

A study was conducted to evaluate the antibody response of Cuban HIV-1 seropositive patients against synthetic peptides of V3 loop of HIV-1 gp 120 due to the molecular findings of mutations that could have some important clinic and epidemiologic implications. We studied sera from 211 individuals with viruses classified as B subtype. Synthetic peptides designed from V3 loop (GPGR, GWGR and GRGR) sequences, were used in an indirect Elisa. High reactivity against these peptides was detected. 62 (percent) of the patients that reacted to GRGR and GWGR peptides as well as non reactive patients had a rapid progression while only 25 (percent) of patients that reacted to GPGR peptide had the similar progression with significance p <0.005. There is a relationship between the promiscuous or dual use of correceptor and the specific response in Elisa. An increase of incidence of these mutations has been observed since the 90's.
机译:由于可以具有一些重要诊所和流行病学意义的突变的分子结果,进行了研究以评估古巴HIV-1血清阳性患者对HIV-1 GP 120的合成肽的抗体反应。我们研究了211名个体的血清,病毒分类为B亚型。由V3环(GPGR,GWGR和GRGR)序列设计的合成肽用于间接ELISA。检测对这些肽的高反应性。 62(百分比)对GRGR和GWGR肽以及非反应性患者反应的患者的进展快,而对GPGR肽反应的患者仅有25(百分比)的患者具有类似的进展,具有显着性P <0.005。在Elisa的混杂或双重使用之间存在关系与ELISA的特定反应之间存在关系。自90年代以来,已经观察到这些突变的发生率的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号